BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 994014)

  • 1. Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.
    Rose HJ; Pruitt AW; Dayton PG; McNay JL
    J Pharmacol Exp Ther; 1976 Dec; 199(3):490-7. PubMed ID: 994014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of experimental azotemia on renal clearance of furosemide in the dog.
    Rose HJ; Pruitt AW; McNay JL
    J Pharmacol Exp Ther; 1976 Jan; 196(1):238-47. PubMed ID: 1246013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the adaptation in sodium excretion in chronic uremia. The effects of "proportional reduction" of sodium intake.
    Schmidt RW; Bourgoignie JJ; Bricker NS
    J Clin Invest; 1974 Jun; 53(6):1736-41. PubMed ID: 4830234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the control of sodium excretion in experimental uremia.
    Schultze RG; Shapiro HS; Bricker NS
    J Clin Invest; 1969 May; 48(5):869-77. PubMed ID: 5780197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters.
    Lambert C; Larose P; Ong H; Gutkowska J; du Souich P
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):181-99. PubMed ID: 3909271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs.
    Berg KJ; Loew D
    Scand J Clin Lab Invest; 1977 Apr; 37(2):125-31. PubMed ID: 616038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubular sites of furosemide natriuresis in volume-replaced and volume-depleted conscious rats.
    Christensen S; Steiness E; Christensen H
    J Pharmacol Exp Ther; 1986 Oct; 239(1):211-8. PubMed ID: 3761193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic characterization of posture-related diuretic and saluretic responses to furosemide in humans.
    Okaniwa T; Echizen H; Ishizaki T; Kasao M; Iizuka T
    J Pharmacol Exp Ther; 1990 Nov; 255(2):716-23. PubMed ID: 2147037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ouabain on the renal response to furosemide.
    López JM; Roncoroni A; Yeyati N; Villamil MF
    Acta Physiol Lat Am; 1975; 25(4):347-52. PubMed ID: 1234701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.
    Finco DR; Duncan JR
    J Am Vet Med Assoc; 1976 Apr; 168(7):593-601. PubMed ID: 1270342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the diuretic and natriuretic effect of furosemide by the calcium antagonist nifedipine.
    Piryova B; Girchev R
    Acta Physiol Pharmacol Bulg; 1989; 15(1):13-8. PubMed ID: 2773646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.
    Chennavasin P; Seiwell R; Brater DC
    J Pharmacol Exp Ther; 1980 Oct; 215(1):77-81. PubMed ID: 7452492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
    Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion.
    Martino JA; Earley LE
    J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of renal clearance of furosemide in man by azotemia.
    Rose HJ; O'Malley K; Pruitt AW
    Clin Pharmacol Ther; 1977 Feb; 21(2):141-6. PubMed ID: 837633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects.
    Sechi LA; Marigliano A; Tedde R
    Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.